Lei Yao Selected Research

Lei Yao Research Topics

Disease

55	Neoplasms (Cancer) 03/2022 - 01/2002
20	Breast Neoplasms (Breast Cancer) 01/2021 - 07/2010
13	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2021 - 03/2003
11	Glioma (Gliomas) 01/2019 - 11/2011
9	Inflammation (Inflammations) 01/2022 - 01/2006
8	Neoplasm Metastasis (Metastasis) 11/2021 - 08/2011
6	Colorectal Neoplasms (Colorectal Cancer) 03/2022 - 03/2003
6	Infections 10/2021 - 06/2013
5	Myocardial Infarction 01/2022 - 10/2009
5	Hemorrhage 01/2018 - 08/2011
5	Brain Neoplasms (Brain Tumor) 07/2016 - 01/2012
4	Cholangiocarcinoma 01/2022 - 01/2015
4	Hypertension (High Blood Pressure) 01/2022 - 08/2010
4	Hepatocellular Carcinoma (Hepatoma) 12/2021 - 02/2013
4	Reperfusion Injury 12/2021 - 04/2012
4	Fibrosis (Cirrhosis) 12/2021 - 07/2008
4	Lung Neoplasms (Lung Cancer) 01/2021 - 01/2018
4	Adenocarcinoma 01/2020 - 01/2011
4	Body Weight (Weight, Body) 12/2019 - 06/2009
4	Alzheimer Disease (Alzheimer's Disease) 03/2016 - 06/2013
4	Radiation Pneumonitis 12/2014 - 08/2010
3	Ischemia 01/2022 - 06/2009
3	Obesity 01/2022 - 01/2018
3	Chronic Pain 10/2020 - 01/2018
3	Glioblastoma (Glioblastoma Multiforme) 01/2020 - 01/2013
3	Vitiligo 10/2017 - 12/2012
2	Pain (Aches) 02/2022 - 01/2018
2	Colonic Neoplasms (Colon Cancer) 01/2022 - 01/2020
2	Hypoxia (Hypoxemia) 12/2021 - 11/2021
2	Wounds and Injuries (Trauma) 12/2021 - 01/2021
2	Hypertrophy 12/2021 - 11/2007
2	Sporotrichosis 10/2021 - 12/2020
2	Acute Lung Injury 05/2021 - 06/2020
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2021 - 01/2018
2	Pathologic Processes 01/2021 - 10/2020
2	Carcinogenesis 01/2021 - 01/2018
2	Mycoses (Diseases, Fungus) 12/2020 - 02/2014
2	Hepatitis 01/2020 - 01/2012
2	Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left) 12/2019 - 02/2010
2	Esophageal Neoplasms (Esophageal Cancer) 04/2018 - 11/2016
2	Calculi (Calculus) 12/2016 - 10/2016

Drug/Important Bio-Agent (IBA)

18	Pharmaceutical PreparationsIBA 03/2022 - 03/2003
16	Proteins (Proteins, Gene)FDA Link 01/2022 - 08/2011
12	ORALIT (ORS)IBA 01/2012 - 07/2010
11	Biomarkers (Surrogate Marker)IBA 01/2022 - 12/2013
8	MicroRNAs (MicroRNA)IBA 12/2021 - 12/2010
8	Paclitaxel (Taxol)FDA LinkGeneric 05/2014 - 11/2011
6	Messenger RNA (mRNA)IBA 01/2022 - 01/2012
6	Peptides (Polypeptides)IBA 01/2014 - 01/2013
5	Interleukin-6 (Interleukin 6)IBA 01/2022 - 12/2012
5	Therapeutic UsesIBA 12/2021 - 12/2019
5	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 04/2020 - 11/2004
5	monomethoxypolyethyleneglycol- polylactide block copolymerIBA 03/2014 - 01/2013
4	huoxue qianyangIBA 01/2022 - 12/2019
4	1-phenyl-3,3-dimethyltriazene (PDT)IBA 01/2022 - 08/2019
4	Matrix Metalloproteinases (MMPs)IBA 07/2013 - 01/2013
3	Volatile Oils (Essential Oils)IBA 04/2022 - 06/2013
3	Circular RNAIBA 01/2022 - 01/2021
3	Sirtuin 1IBA 01/2022 - 12/2019
3	Long Noncoding RNAIBA 12/2021 - 01/2019
3	CytokinesIBA 12/2021 - 12/2012
3	ChemokinesIBA 01/2021 - 04/2002
3	Amyloid beta-PeptidesIBA 03/2016 - 03/2014
3	Ethylene Glycol (Monoethylene Glycol)IBA 01/2014 - 03/2012
3	arginylprolineIBA 12/2011 - 09/2010
3	prolyl-proline (Pro-Pro)IBA 12/2011 - 09/2010
3	arginylarginine (Arg-Arg)IBA 12/2011 - 09/2010
3	Cytochrome P-450 Enzyme System (Cytochrome P450)IBA 07/2010 - 07/2010
2	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2022 - 03/2017
2	CholesterolIBA 01/2022 - 10/2020
2	InflammasomesIBA 12/2021 - 10/2020
2	Androgen Receptors (Androgen Receptor)IBA 11/2021 - 01/2021
2	Small Interfering RNA (siRNA)IBA 10/2021 - 09/2013
2	Melanins (Melanin)IBA 10/2021 - 03/2021
2	Caspase 3 (Caspase-3)IBA 08/2021 - 01/2021
2	Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA 05/2021 - 01/2004
2	SolutionsIBA 01/2021 - 07/2013
2	Antineoplastic Agents (Antineoplastics)IBA 01/2021 - 12/2013
2	LipidsIBA 06/2020 - 07/2013
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 05/2020 - 07/2010
2	Glycine Receptors (Glycine Receptor)IBA 01/2020 - 01/2018
2	AntigensIBA 01/2020 - 01/2018
2	CannabinoidsIBA 01/2020 - 01/2018
2	CurcuminIBA 01/2019 - 05/2017
2	Clostridium perfringens epsilon-toxinIBA 01/2018 - 01/2017
2	Oxygen (Dioxygen)IBA 01/2018 - 09/2002
2	AlbuminsIBA 07/2017 - 01/2016

Therapy/Procedure

19	Therapeutics 04/2022 - 09/2002
5	Drug Therapy (Chemotherapy) 03/2022 - 08/2010
5	Radiotherapy 07/2016 - 12/2012
4	Stents 01/2021 - 10/2016
4	Transplantation 10/2017 - 11/2004
3	Photochemotherapy (Photodynamic Therapy) 01/2022 - 12/2020
3	Immunotherapy 01/2022 - 01/2018
3	Lithotripsy (Extracorporeal Shockwave Lithotripsy) 10/2016 - 08/2011
3	Conformal Radiotherapy 12/2014 - 08/2010
2	Catheter Ablation 07/2021 - 07/2019
2	Analgesia 10/2020 - 01/2018
2	Aftercare (After-Treatment) 12/2019 - 10/2018
2	Chemoradiotherapy 04/2018 - 07/2014